Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity.

[1]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[2]  J. Gibb,et al.  Influence of methamphetamine and neuroleptic drugs on tyrosine hydroxylase activity. , 1974, European journal of pharmacology.

[3]  G. Cohen,et al.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. , 1975, Biochemical pharmacology.

[4]  L. Seiden,et al.  Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. , 1976, Drug and alcohol dependence.

[5]  S. Iversen,et al.  Selective 60HDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats , 1976 .

[6]  M. E. Lewis,et al.  Nerve growth factor: effects on d-amphetamine-induced activity and brain monoamines , 1979, Brain Research.

[7]  S. Hill,et al.  Computerized transaxial tomographic and neuropsychol evaluations in chronic alcoholics and heroin abusers. , 1979, The American journal of psychiatry.

[8]  J. Gibb,et al.  Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. , 1980, The Journal of pharmacology and experimental therapeutics.

[9]  J. Gibb,et al.  Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nuclei , 1980, Neuropharmacology.

[10]  L. Cala,et al.  COMPUTERIZED AXIAL TOMOGRAPHY IN THE DETECTION OF BRAIN DAMAGE , 1980, The Medical journal of Australia.

[11]  B. Covino,et al.  Differential Sensitivities of Mammalian Nerve Fibers to Local Anesthetic Agents , 1980, Anesthesiology.

[12]  H. Thoenen,et al.  Purification of a new neurotrophic factor from mammalian brain. , 1982, The EMBO journal.

[13]  L. Seiden,et al.  Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes , 1983, Brain Research.

[14]  L. Seiden,et al.  Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine , 1983, Neuropharmacology.

[15]  H. Thoenen,et al.  Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. , 1985, The EMBO journal.

[16]  C. J. Schmidt,et al.  Role of dopamine in the neurotoxic effects of methamphetamine. , 1985, The Journal of pharmacology and experimental therapeutics.

[17]  T. Robinson,et al.  Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.

[18]  G. Hanson,et al.  Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. , 1986, The Journal of pharmacology and experimental therapeutics.

[19]  R. Levi‐montalcini,et al.  The nerve growth factor 35 years later. , 1987, Science.

[20]  J. B. Justice,et al.  Effects of cocaine on release and uptake of dopamine in vivo: Differentiation by mathematical modeling , 1988, Pharmacology Biochemistry and Behavior.

[21]  A. Howlett,et al.  Determination and characterization of a cannabinoid receptor in rat brain. , 1988, Molecular pharmacology.

[22]  Nora D. Volkow,et al.  Modifications radiologiques et neurologiques chez les toxicomanes: étude par résonance magnétique , 1988 .

[23]  G. Hanson,et al.  Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat. , 1988, The Journal of pharmacology and experimental therapeutics.

[24]  H. Thoenen,et al.  Molecular cloning and expression of brain-derived neurotrophic factor , 1989, Nature.

[25]  T. Insel,et al.  3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. , 1989, The Journal of pharmacology and experimental therapeutics.

[26]  G. Higgins,et al.  Localization of nerve growth factor receptor messenger RNA and protein in the adult rat brain , 1989, Experimental Neurology.

[27]  Yves-Alain Barde,et al.  Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture , 1990, Neuron.

[28]  R. Spanagel,et al.  The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis Study , 1990, Journal of neurochemistry.

[29]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[30]  S. Southwick,et al.  Clinical features of cocaine induced paranoia. , 1991, NIDA research monograph.

[31]  D. Goeddel,et al.  Primary structure and biological activity of human brain-derived neurotrophic factor. , 1991, Endocrinology.

[32]  K. Davis,et al.  Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.

[33]  G. Yancopoulos,et al.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra , 1991, Nature.

[34]  V. Wooten,et al.  Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. , 1991, The American journal of psychiatry.

[35]  T. Blundell,et al.  Crystallization and characterization of the high molecular weight form of nerve growth factor (7 S NGF). , 1991, Journal of molecular biology.

[36]  J. Lowinson,et al.  Strain-specific facilitation of dopamine efflux by Δ 9-tetrahydrocannabinol in the nucleus accumbens of rat: An in vivo microdialysis study , 1991, Neuroscience Letters.

[37]  S. O'dell,et al.  Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine , 1992, Brain Research.

[38]  A. Deutch,et al.  Dopaminergic mechanisms in the pathogenesis of schizophrenia 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  R. North,et al.  Opioids excite dopamine neurons by hyperpolarization of local interneurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  B. Woods,et al.  Quantitative magnetic resonance imaging in heroin- and cocaine-dependent men: A preliminary study , 1992, Psychiatry Research: Neuroimaging.

[41]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[42]  S. Korsching,et al.  The neurotrophic factor concept: a reexamination , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  M. Gold,et al.  Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine. , 1993, The Psychiatric clinics of North America.

[44]  O. Lindvall,et al.  Increased production of the TrkB protein tyrosine kinase receptor after brain insults , 1993, Neuron.

[45]  E. J. Nestler.  Cellular responses to chronic treatment with drugs of abuse. , 1993, Critical reviews in neurobiology.

[46]  N. R. Richardson,et al.  A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats. , 1994, Drug and alcohol dependence.

[47]  M E Greenberg,et al.  Requirement for BDNF in activity-dependent survival of cortical neurons. , 1994, Science.

[48]  R. Feeney,et al.  Cloning of a non-catalytic form of human trkBand distribution of messenger RNA for trkB in human brain , 1994, Neuroscience.

[49]  R. Klein.  Role of neurotrophins in mouse neuronal development , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  J. Siuciak,et al.  In Situ Hybridization of trkB and trkC Receptor mRNA in Rat Forebrain and Association with High‐affinity Binding of [125I]BDNF, [125I]NT‐4/5 and [125I]NT‐3 , 1994, The European journal of neuroscience.

[51]  C. Altar,et al.  Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  D. Pfaff,et al.  In situ hybridization detection of trka mRNA in brain: Distribution, colocalization with p75NGFR and up‐regulation by nerve growth factor , 1994, The Journal of comparative neurology.

[53]  Rhonda,et al.  Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  E. Mufson,et al.  TrkA‐immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin , 1994, The Journal of comparative neurology.

[55]  J. Siuciak,et al.  Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3 , 1994, Brain Research.

[56]  G. Di Chiara,et al.  Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Galiègue,et al.  Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. , 1995, European journal of biochemistry.

[58]  B. Hempstead,et al.  p75 and Trk: A two-receptor system , 1995, Trends in Neurosciences.

[59]  C. Altar,et al.  Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[60]  M. Barbacid.  Structural and Functional Properties of the TRK Family of Neurotrophin Receptors , 1995, Annals of the New York Academy of Sciences.

[61]  L. Acsády,et al.  Expression of NGF and NT3 mRNAs in Hippocampal Interneurons Innervated by the GABAergic Septohippocampal Pathway , 1996, The Journal of Neuroscience.

[62]  J. Stapleton,et al.  Cerebral perfusion in early and late opiate withdrawal: a technetium-99m-HMPAO SPECT study , 1996, Psychiatry Research: Neuroimaging.

[63]  H. Thoenen,et al.  Autocrine—paracrine Regulation of Hippocampal Neuron Survival by IGF‐1 and the Neurotrophins BDNF, NT‐3 and NT‐4 , 1996, The European journal of neuroscience.

[64]  R. Duman,et al.  Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  R. Macias,et al.  NGF in experimental models of parkinson disease , 1996, Molecular and chemical neuropathology.

[66]  M. Kuhar,et al.  Neurochemical changes in cocaine withdrawal. , 1996, Trends in pharmacological sciences.

[67]  S. Skaper,et al.  Nerve growth factor: from neurotrophin to neurokine , 1996, Trends in Neurosciences.

[68]  M. Bothwell.  p75NTR: A Receptor After All , 1996, Science.

[69]  Charles C. Lee,et al.  The effects of nerve growth factor and ganglioside GM1 on the anti-proliferative activity of cocaine in PC 12 cells , 1996 .

[70]  G. Aghajanian,et al.  5-HT2A Receptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex , 1997, The Journal of Neuroscience.

[71]  G. Di Chiara,et al.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. , 1997, Science.

[72]  R. Christopher Pierce,et al.  A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants , 1997, Brain Research Reviews.

[73]  E. French.  Δ 9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors , 1997, Neuroscience Letters.

[74]  D. Kaplan,et al.  Ligand-induced down-regulation of trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons , 1997, Neuroscience.

[75]  D. Kaplan,et al.  Signal transduction by the neutrophin receptors , 1997 .

[76]  M. Chao,et al.  Neurotrophin receptors: mediators of life and death 1 Published on the World Wide Web on 21 October 1997. 1 , 1998, Brain Research Reviews.

[77]  J G Csernansky,et al.  Limbic-cortical neuronal damage and the pathophysiology of schizophrenia. , 1998, Schizophrenia bulletin.

[78]  S. Furukawa,et al.  Medial nigral dopamine neurons have rich neurotrophin support in humans. , 1998 .

[79]  S. Kasper,et al.  Cerebral CT findings in male opioid-dependent patients: Stereological, planimetric and linear measurements , 1998, Psychiatry Research: Neuroimaging.

[80]  C. Altar,et al.  Neurotrophin trafficking by anterograde transport , 1998, Trends in Neurosciences.

[81]  Y. Agid,et al.  Tyrosine kinase B messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study , 1998, Neuroscience.

[82]  C. Ibáñez.  Emerging themes in structural biology of neurotrophic factors , 1998, Trends in Neurosciences.

[83]  K. Seroogy,et al.  Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: A double‐label in situ hybridization study , 1999, The Journal of comparative neurology.

[84]  M. LaVoie,et al.  Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine , 1999, The Journal of Neuroscience.

[85]  A. Ameri.  The effects of cannabinoids on the brain , 1999, Progress in Neurobiology.

[86]  T. Zetterström,et al.  Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain , 1999, Neuropharmacology.

[87]  J. White,et al.  Mechanisms of fatal opioid overdose. , 1999, Addiction.

[88]  F. Hallböök.  Evolution of the vertebrate neurotrophin and Trk receptor gene families , 1999, Current Opinion in Neurobiology.

[89]  P. Soubrié,et al.  Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. , 2000, Journal of neurophysiology.

[90]  G. Gessa,et al.  Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[91]  D. Zachor,et al.  Cocaine inhibits NGF-induced PC12 cells differentiation through D1-type dopamine receptors , 2000, Brain Research.

[92]  D. Zachor,et al.  Cocaine inhibition of neuronal differentiation in NGF-induced PC12 cells is independent of ras signaling , 2000, International Journal of Developmental Neuroscience.

[93]  S. Robinson,et al.  Perinatal opioids reduce striatal nerve growth factor content in rat striatum. , 2001, European journal of pharmacology.

[94]  M. Pistis,et al.  Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study , 2002, The European journal of neuroscience.

[95]  A. Somogyi,et al.  Diacetylmorphine degradation to 6-monoacetylmorphine and morphine in cell culture: implications for in vitro studies. , 2002, European journal of pharmacology.

[96]  J. Mao,et al.  Neuronal Apoptosis Associated with Morphine Tolerance: Evidence for an Opioid-Induced Neurotoxic Mechanism , 2002, The Journal of Neuroscience.

[97]  M. Herkenham,et al.  International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.

[98]  G. Meredith,et al.  Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration , 2002, Brain Research.

[99]  Shuxian Hu,et al.  Morphine induces apoptosis of human microglia and neurons , 2002, Neuropharmacology.

[100]  M. Gnegy,et al.  Repeated, intermittent treatment with amphetamine induces neurite outgrowth in rat pheochromocytoma cells (PC12 cells) , 2002, Brain Research.

[101]  H. Nawa,et al.  Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients , 2002, Psychiatry Research.

[102]  J. Kim,et al.  ProNGF Induces p75-Mediated Death of Oligodendrocytes following Spinal Cord Injury , 2002, Neuron.

[103]  C. Oliveira,et al.  Toxic Effects of Opioid and Stimulant Drugs on Undifferentiated PC12 Cells , 2002, Annals of the New York Academy of Sciences.

[104]  H. Danker-Hopfe,et al.  Chronic Cannabis Abuse Raises Nerve Growth Factor Serum Concentrations in Drug-Naive Schizophrenic Patients , 2003, Journal of psychopharmacology.

[105]  K. Hashimoto,et al.  Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls , 2003, Neuroscience Letters.

[106]  B. Melchior,et al.  Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection , 2003, Experimental Neurology.

[107]  M. Narita,et al.  Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine , 2003, Neuroscience.

[108]  V. Parikh,et al.  Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome , 2003, Schizophrenia Research.

[109]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[110]  G. Vickers,et al.  The effect of haloperidol on cocaine self-administration is augmented with repeated administrations , 2004, Psychopharmacology.

[111]  L. Parsons,et al.  Neurobiological mechanisms in the transition from drug use to drug dependence , 2004, Neuroscience & Biobehavioral Reviews.

[112]  R. Hampson,et al.  Cannabinoid physiology and pharmacology: 30 years of progress , 2004, Neuropharmacology.

[113]  M. Meyer,et al.  Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[114]  Q. Yan,et al.  Prenatal cocaine exposure decreases brain-derived neurotrophic factor proteins in the rat brain , 2004, Brain Research.

[115]  H. Danker-Hopfe,et al.  Brain-derived neurotrophic factor serum concentrations are increased in drug-naïve schizophrenic patients with chronic cannabis abuse and multiple substance abuse , 2004, Neuroscience Letters.

[116]  J. Gibb,et al.  Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

[117]  C. Ríos,et al.  Ventricular injection of nerve growth factor increases dopamine content in the striata of MPTP-treated mice , 1992, Neurochemical Research.

[118]  J. Thome,et al.  Neurotrophic factors and the pathophysiology of schizophrenic psychoses , 2004, European Psychiatry.

[119]  F. Angelucci,et al.  Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. , 2004, Progress in brain research.

[120]  R. Levi‐montalcini.  The nerve growth factor and the neuroscience chess board. , 2003, Progress in brain research.

[121]  H. Fibiger,et al.  Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions ofd-amphetamine and apomorphine , 2005, Psychopharmacology.

[122]  P. Celada,et al.  The activation of 5‐HT2A receptors in prefrontal cortex enhances dopaminergic activity , 2005, Journal of neurochemistry.

[123]  Yong-Ku Kim,et al.  High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users , 2005, Neuroscience Letters.

[124]  R. Hellweg,et al.  Impact of Levodopa on Reduced Nerve Growth Factor Levels in Patients With Parkinson Disease , 2005, Clinical neuropharmacology.

[125]  Diane M. Smith,et al.  Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis , 1990, Psychopharmacology.

[126]  Abraham Weizman,et al.  The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia , 2005, European Neuropsychopharmacology.

[127]  F. Angelucci,et al.  BDNF in schizophrenia, depression and corresponding animal models , 2005, Molecular Psychiatry.

[128]  K. Hashimoto,et al.  Association study between brain‐derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[129]  X. Zhang,et al.  Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics , 2005, Neuroscience Letters.

[130]  S. Tsai,et al.  Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. , 2005, Brain research. Molecular brain research.

[131]  M. Poo,et al.  BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal , 2006, Nature Neuroscience.

[132]  E. Cook,et al.  An association study of the brain‐derived neurotrophic factor Val66Met polymorphism and amphetamine response , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[133]  Chien-Te Lee,et al.  Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. , 2006, Journal of psychiatric research.

[134]  A. Baba,et al.  Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice , 2006, Neuropharmacology.

[135]  R. Chaturvedi,et al.  Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease , 2006, Neuroscience Letters.

[136]  M. Filip,et al.  Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal , 2006, Brain Research.

[137]  Yoko Hirata,et al.  Differential effect of nerve growth factor on dopaminergic neurotoxin‐induced apoptosis , 2006, Journal of neurochemistry.

[138]  Q. Yan,et al.  RNA interference-mediated inhibition of brain-derived neurotrophic factor expression increases cocaine's cytotoxicity in cultured cells , 2007, Neuroscience Letters.

[139]  F. Fumagalli,et al.  Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex , 2007, The European journal of neuroscience.

[140]  Peter F. Buckley,et al.  Neurotrophins and schizophrenia , 2007, Schizophrenia Research.

[141]  P. Bria,et al.  Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor , 2007 .

[142]  J. McGinty,et al.  A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats , 2007, The European journal of neuroscience.

[143]  G. Schoenbaum,et al.  A role for BDNF in cocaine reward and relapse , 2007, Nature Neuroscience.

[144]  P. Tonali,et al.  Chronic amphetamine treatment reduces NGF and BDNF in the rat brain , 2007, European Neuropsychopharmacology.

[145]  Karl Mann,et al.  Dorsolateral Prefrontal Cortex N-Acetylaspartate/Total Creatine (NAA/tCr) Loss in Male Recreational Cannabis Users , 2007, Biological Psychiatry.

[146]  Joseph P. Huston,et al.  Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors , 2007, Progress in Neurobiology.

[147]  Alexander Strobel,et al.  Interaction between BDNF Val66Met and Dopamine Transporter Gene Variation Influences Anxiety-Related Traits , 2007, Neuropsychopharmacology.

[148]  A. Sorkin,et al.  Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations , 2007, Journal of neurochemistry.

[149]  C. Caltagirone,et al.  Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers , 2008, European Neuropsychopharmacology.

[150]  R. L. Sutton,et al.  Voluntary exercise or amphetamine treatment, but not the combination, increases hippocampal brain-derived neurotrophic factor and synapsin I following cortical contusion injury in rats , 2008, Neuroscience.

[151]  Ikuko Miyazaki,et al.  Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease , 2009, Neurotoxicity Research.